Effect  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
intensive  ||| S:10 E:20 ||| JJ
exercise  ||| S:20 E:29 ||| NN
on  ||| S:29 E:32 ||| IN
plasmatic  ||| S:32 E:42 ||| JJ
neutrophil  ||| S:42 E:53 ||| JJ
elastase  ||| S:53 E:62 ||| JJ
level  ||| S:62 E:68 ||| NN
in  ||| S:68 E:71 ||| IN
eventing  ||| S:71 E:80 ||| NN
and  ||| S:80 E:84 ||| CC
endurance  ||| S:84 E:94 ||| JJ
horses  ||| S:94 E:101 ||| NNS
Intensive  ||| S:101 E:111 ||| JJ
exercise  ||| S:111 E:120 ||| NN
induces  ||| S:120 E:128 ||| VBZ
a  ||| S:128 E:130 ||| DT
systemic  ||| S:130 E:139 ||| JJ
inflammatory  ||| S:139 E:152 ||| JJ
response  ||| S:152 E:161 ||| NN
characterised  ||| S:161 E:175 ||| NN
by  ||| S:175 E:178 ||| IN
an  ||| S:178 E:181 ||| DT
increase  ||| S:181 E:190 ||| NN
of  ||| S:190 E:193 ||| IN
blood  ||| S:193 E:199 ||| NN
neutrophil  ||| S:199 E:210 ||| NN
count  ||| S:210 E:216 ||| NN
and  ||| S:216 E:220 ||| CC
myeloperoxidase  ||| S:220 E:236 ||| NNS
( ||| S:236 E:237 ||| -LRB-
MPO ||| S:237 E:240 ||| NNP
)  ||| S:240 E:242 ||| -RRB-
release ||| S:242 E:249 ||| NN
.  ||| S:249 E:251 ||| .
Neutrophil  ||| S:251 E:262 ||| JJ
elastase  ||| S:262 E:271 ||| NNS
( ||| S:271 E:272 ||| -LRB-
NE ||| S:272 E:274 ||| NNP
)  ||| S:274 E:276 ||| -RRB-
could  ||| S:276 E:282 ||| MD
also  ||| S:282 E:287 ||| RB
contribute  ||| S:287 E:298 ||| VB
to  ||| S:298 E:301 ||| TO
tissues  ||| S:301 E:309 ||| VB
lesions  ||| S:309 E:317 ||| VBN
by  ||| S:317 E:320 ||| IN
its  ||| S:320 E:324 ||| PRP$
proteinase  ||| S:324 E:335 ||| JJ
activities ||| S:335 E:345 ||| NNS
.  ||| S:345 E:347 ||| .
To  ||| S:347 E:350 ||| TO
compare  ||| S:350 E:358 ||| VB
plasmatic  ||| S:358 E:368 ||| JJ
NE  ||| S:368 E:371 ||| NN
concentrations  ||| S:371 E:386 ||| NNS
before  ||| S:386 E:393 ||| IN
and  ||| S:393 E:397 ||| CC
after  ||| S:397 E:403 ||| IN
different  ||| S:403 E:413 ||| JJ
forms  ||| S:413 E:419 ||| NNS
of  ||| S:419 E:422 ||| IN
intensive  ||| S:422 E:432 ||| JJ
exercise ||| S:432 E:440 ||| NN
.  ||| S:440 E:442 ||| .
EDTA  ||| S:442 E:447 ||| NNP
blood  ||| S:447 E:453 ||| NN
samples  ||| S:453 E:461 ||| NNS
were  ||| S:461 E:466 ||| VBD
taken  ||| S:466 E:472 ||| VBN
from  ||| S:472 E:477 ||| IN
51  ||| S:477 E:480 ||| CD
eventing  ||| S:480 E:489 ||| CD
horses  ||| S:489 E:496 ||| NNS
( ||| S:496 E:497 ||| -LRB-
EvH ||| S:497 E:500 ||| NNP
)  ||| S:500 E:502 ||| -RRB-
and  ||| S:502 E:506 ||| CC
32  ||| S:506 E:509 ||| CD
endurance  ||| S:509 E:519 ||| CD
horses  ||| S:519 E:526 ||| NNS
( ||| S:526 E:527 ||| -LRB-
EndH ||| S:527 E:531 ||| NNP
)  ||| S:531 E:533 ||| -RRB-
were  ||| S:533 E:538 ||| VBD
sampled  ||| S:538 E:546 ||| VBN
before  ||| S:546 E:553 ||| IN
the  ||| S:553 E:557 ||| DT
race  ||| S:557 E:562 ||| NN
( ||| S:562 E:563 ||| -LRB-
T0 ||| S:563 E:565 ||| NNP
) ||| S:565 E:566 ||| -RRB-
.  ||| S:566 E:568 ||| .
Blood  ||| S:568 E:574 ||| NN
sampling  ||| S:574 E:583 ||| NNS
was  ||| S:583 E:587 ||| VBD
performed  ||| S:587 E:597 ||| VBN
2  ||| S:597 E:599 ||| CD
h  ||| S:599 E:601 ||| NNS
( ||| S:601 E:602 ||| -LRB-
T1 ||| S:602 E:604 ||| NNP
)  ||| S:604 E:606 ||| -RRB-
after  ||| S:606 E:612 ||| IN
completing  ||| S:612 E:623 ||| VBG
either  ||| S:623 E:630 ||| DT
phase  ||| S:630 E:636 ||| NN
D  ||| S:636 E:638 ||| NNP
of  ||| S:638 E:641 ||| IN
a  ||| S:641 E:643 ||| DT
one  ||| S:643 E:647 ||| NN
or  ||| S:647 E:650 ||| CC
2  ||| S:650 E:652 ||| CD
star  ||| S:652 E:657 ||| NN
eventing  ||| S:657 E:666 ||| NN
competition  ||| S:666 E:678 ||| NN
( ||| S:678 E:679 ||| -LRB-
n  ||| S:679 E:681 ||| CD
=  ||| S:681 E:683 ||| SYM
51 ||| S:683 E:685 ||| CD
) ||| S:685 E:686 ||| -RRB-
,  ||| S:686 E:688 ||| ,
or  ||| S:688 E:691 ||| CC
a  ||| S:691 E:693 ||| DT
120  ||| S:693 E:697 ||| CD
or  ||| S:697 E:700 ||| CC
160  ||| S:700 E:704 ||| CD
km  ||| S:704 E:707 ||| CD
endurance  ||| S:707 E:717 ||| JJ
race  ||| S:717 E:722 ||| NN
( ||| S:722 E:723 ||| -LRB-
n  ||| S:723 E:725 ||| CD
=  ||| S:725 E:727 ||| SYM
32 ||| S:727 E:729 ||| CD
) ||| S:729 E:730 ||| -RRB-
.  ||| S:730 E:732 ||| .
Plasmatic  ||| S:732 E:742 ||| NNP
NE  ||| S:742 E:745 ||| NNP
and  ||| S:745 E:749 ||| CC
MPO  ||| S:749 E:753 ||| NNP
were  ||| S:753 E:758 ||| VBD
measured  ||| S:758 E:767 ||| VBN
by  ||| S:767 E:770 ||| IN
a  ||| S:770 E:772 ||| DT
specific  ||| S:772 E:781 ||| JJ
equine  ||| S:781 E:788 ||| JJ
ELISA ||| S:788 E:793 ||| NNP
.  ||| S:793 E:795 ||| .
Neutrophil  ||| S:795 E:806 ||| JJ
counts  ||| S:806 E:813 ||| NNS
and  ||| S:813 E:817 ||| CC
creatine  ||| S:817 E:826 ||| JJ
kinase  ||| S:826 E:833 ||| NNS
( ||| S:833 E:834 ||| -LRB-
CK ||| S:834 E:836 ||| NNP
)  ||| S:836 E:838 ||| -RRB-
levels  ||| S:838 E:845 ||| NNS
were  ||| S:845 E:850 ||| VBD
also  ||| S:850 E:855 ||| RB
measured ||| S:855 E:863 ||| VBN
.  ||| S:863 E:865 ||| .
A  ||| S:865 E:867 ||| DT
Wilcox  ||| S:867 E:874 ||| NNP
on  ||| S:874 E:877 ||| IN
test  ||| S:877 E:882 ||| NN
for  ||| S:882 E:886 ||| IN
paired  ||| S:886 E:893 ||| JJ
samples  ||| S:893 E:901 ||| NNS
was  ||| S:901 E:905 ||| VBD
used  ||| S:905 E:910 ||| VBN
to  ||| S:910 E:913 ||| TO
compare  ||| S:913 E:921 ||| VB
mean  ||| S:921 E:926 ||| JJ
values  ||| S:926 E:933 ||| NNS
of  ||| S:933 E:936 ||| IN
neutrophils ||| S:936 E:947 ||| NN
,  ||| S:947 E:949 ||| ,
CK ||| S:949 E:951 ||| NNP
,  ||| S:951 E:953 ||| ,
MPO  ||| S:953 E:957 ||| NNP
and  ||| S:957 E:961 ||| CC
NE  ||| S:961 E:964 ||| NNP
at  ||| S:964 E:967 ||| IN
T0  ||| S:967 E:970 ||| NNP
and  ||| S:970 E:974 ||| CC
T1  ||| S:974 E:977 ||| CD
in  ||| S:977 E:980 ||| IN
EvH  ||| S:980 E:984 ||| JJ
and  ||| S:984 E:988 ||| CC
in  ||| S:988 E:991 ||| IN
EndH ||| S:991 E:995 ||| JJ
.  ||| S:995 E:997 ||| .
Correlations  ||| S:997 E:1010 ||| NNP
were  ||| S:1010 E:1015 ||| VBD
calculated  ||| S:1015 E:1026 ||| VBN
between  ||| S:1026 E:1034 ||| IN
all  ||| S:1034 E:1038 ||| PDT
the  ||| S:1038 E:1042 ||| DT
4  ||| S:1042 E:1044 ||| CD
parameters  ||| S:1044 E:1055 ||| NNS
in  ||| S:1055 E:1058 ||| IN
EvH  ||| S:1058 E:1062 ||| JJ
and  ||| S:1062 E:1066 ||| CC
EndH ||| S:1066 E:1070 ||| JJ
.  ||| S:1070 E:1072 ||| .
At  ||| S:1072 E:1075 ||| IN
T0 ||| S:1075 E:1077 ||| NNP
,  ||| S:1077 E:1079 ||| ,
mean  ||| S:1079 E:1084 ||| VBP
NE  ||| S:1084 E:1087 ||| JJ
levels  ||| S:1087 E:1094 ||| NNS
were  ||| S:1094 E:1099 ||| VBD
14.43  ||| S:1099 E:1105 ||| CD
±  ||| S:1105 E:1107 ||| CD
3.63  ||| S:1107 E:1112 ||| CD
ng ||| S:1112 E:1114 ||| CD
/ ||| S:1114 E:1115 ||| CD
ml  ||| S:1115 E:1118 ||| NN
for  ||| S:1118 E:1122 ||| IN
EvH  ||| S:1122 E:1126 ||| JJ
and  ||| S:1126 E:1130 ||| CC
11.7  ||| S:1130 E:1135 ||| CD
±  ||| S:1135 E:1137 ||| CD
2.11  ||| S:1137 E:1142 ||| CD
ng ||| S:1142 E:1144 ||| CD
/ ||| S:1144 E:1145 ||| CD
ml  ||| S:1145 E:1148 ||| NN
for  ||| S:1148 E:1152 ||| IN
EndH ||| S:1152 E:1156 ||| JJ
.  ||| S:1156 E:1158 ||| .
The  ||| S:1158 E:1162 ||| DT
competition  ||| S:1162 E:1174 ||| NN
induced  ||| S:1174 E:1182 ||| VBD
a  ||| S:1182 E:1184 ||| DT
significant  ||| S:1184 E:1196 ||| JJ
increase  ||| S:1196 E:1205 ||| NN
of  ||| S:1205 E:1208 ||| IN
NE  ||| S:1208 E:1211 ||| NNP
levels  ||| S:1211 E:1218 ||| NNS
in  ||| S:1218 E:1221 ||| IN
( ||| S:1221 E:1222 ||| -LRB-
58.57  ||| S:1222 E:1228 ||| FW
±  ||| S:1228 E:1230 ||| FW
24.06  ||| S:1230 E:1236 ||| FW
ng ||| S:1236 E:1238 ||| FW
/ ||| S:1238 E:1239 ||| FW
ml ||| S:1239 E:1241 ||| FW
)  ||| S:1241 E:1243 ||| -RRB-
EvH  ||| S:1243 E:1247 ||| JJ
and  ||| S:1247 E:1251 ||| CC
( ||| S:1251 E:1252 ||| -LRB-
95.74  ||| S:1252 E:1258 ||| FW
±  ||| S:1258 E:1260 ||| FW
22.70  ||| S:1260 E:1266 ||| FW
ng ||| S:1266 E:1268 ||| FW
/ ||| S:1268 E:1269 ||| FW
ml ||| S:1269 E:1271 ||| FW
)  ||| S:1271 E:1273 ||| -RRB-
EndH  ||| S:1273 E:1278 ||| NNP
( ||| S:1278 E:1279 ||| -LRB-
P  ||| S:1279 E:1281 ||| NNP
< ||| S:1281 E:1283 ||| SYM
0.05 ||| S:1283 E:1287 ||| CD
) ||| S:1287 E:1288 ||| -RRB-
.  ||| S:1288 E:1290 ||| .
NE  ||| S:1290 E:1293 ||| NNP
was  ||| S:1293 E:1297 ||| VBD
significantly  ||| S:1297 E:1311 ||| RB
( ||| S:1311 E:1312 ||| -LRB-
P  ||| S:1312 E:1314 ||| NNP
< ||| S:1314 E:1316 ||| SYM
0.0001 ||| S:1316 E:1322 ||| NNP
)  ||| S:1322 E:1324 ||| -RRB-
correlated  ||| S:1324 E:1335 ||| NN
to  ||| S:1335 E:1338 ||| TO
MPO  ||| S:1338 E:1342 ||| NNP
in  ||| S:1342 E:1345 ||| IN
EvH  ||| S:1345 E:1349 ||| NNP
( ||| S:1349 E:1350 ||| -LRB-
r  ||| S:1350 E:1352 ||| LS
=  ||| S:1352 E:1354 ||| SYM
0.293 ||| S:1354 E:1359 ||| CD
)  ||| S:1359 E:1361 ||| -RRB-
and  ||| S:1361 E:1365 ||| CC
EndH  ||| S:1365 E:1370 ||| NNP
( ||| S:1370 E:1371 ||| -LRB-
r  ||| S:1371 E:1373 ||| LS
=  ||| S:1373 E:1375 ||| SYM
0.594 ||| S:1375 E:1380 ||| CD
)  ||| S:1380 E:1382 ||| -RRB-
and  ||| S:1382 E:1386 ||| CC
to  ||| S:1386 E:1389 ||| TO
CK  ||| S:1389 E:1392 ||| NNP
( ||| S:1392 E:1393 ||| -LRB-
r  ||| S:1393 E:1395 ||| LS
=  ||| S:1395 E:1397 ||| SYM
0.297 ||| S:1397 E:1402 ||| CD
)  ||| S:1402 E:1404 ||| -RRB-
in  ||| S:1404 E:1407 ||| IN
EndH  ||| S:1407 E:1412 ||| NNP
( ||| S:1412 E:1413 ||| -LRB-
P  ||| S:1413 E:1415 ||| NNP
< ||| S:1415 E:1417 ||| SYM
0.0001 ||| S:1417 E:1423 ||| NNP
) ||| S:1423 E:1424 ||| -RRB-
.  ||| S:1424 E:1426 ||| .
Neutrophils ||| S:1426 E:1437 ||| NNP
,  ||| S:1437 E:1439 ||| ,
CK  ||| S:1439 E:1442 ||| NNP
and  ||| S:1442 E:1446 ||| CC
MPO  ||| S:1446 E:1450 ||| NNP
were  ||| S:1450 E:1455 ||| VBD
significantly  ||| S:1455 E:1469 ||| RB
increased  ||| S:1469 E:1479 ||| VBN
between  ||| S:1479 E:1487 ||| IN
T0  ||| S:1487 E:1490 ||| NNP
and  ||| S:1490 E:1494 ||| CC
T1  ||| S:1494 E:1497 ||| CD
in  ||| S:1497 E:1500 ||| IN
both  ||| S:1500 E:1505 ||| DT
types  ||| S:1505 E:1511 ||| NNS
of  ||| S:1511 E:1514 ||| IN
horses ||| S:1514 E:1520 ||| NNS
.  ||| S:1520 E:1522 ||| .
Significant  ||| S:1522 E:1534 ||| JJ
increase  ||| S:1534 E:1543 ||| NN
of  ||| S:1543 E:1546 ||| IN
NE  ||| S:1546 E:1549 ||| NNP
( ||| S:1549 E:1550 ||| -LRB-
EndH ||| S:1550 E:1554 ||| NNP
)  ||| S:1554 E:1556 ||| -RRB-
was  ||| S:1556 E:1560 ||| VBD
observed  ||| S:1560 E:1569 ||| VBN
after  ||| S:1569 E:1575 ||| IN
intense  ||| S:1575 E:1583 ||| JJ
exercise  ||| S:1583 E:1592 ||| NN
with  ||| S:1592 E:1597 ||| IN
a  ||| S:1597 E:1599 ||| DT
significant  ||| S:1599 E:1611 ||| JJ
correlation  ||| S:1611 E:1623 ||| NN
between  ||| S:1623 E:1631 ||| IN
NE  ||| S:1631 E:1634 ||| NNP
and  ||| S:1634 E:1638 ||| CC
MPO ||| S:1638 E:1641 ||| NNP
.  ||| S:1641 E:1643 ||| .
The  ||| S:1643 E:1647 ||| DT
huge  ||| S:1647 E:1652 ||| JJ
variability  ||| S:1652 E:1664 ||| NN
in  ||| S:1664 E:1667 ||| IN
MPO  ||| S:1667 E:1671 ||| NNP
and  ||| S:1671 E:1675 ||| CC
NE  ||| S:1675 E:1678 ||| NNP
indicates  ||| S:1678 E:1688 ||| VBZ
that  ||| S:1688 E:1693 ||| IN
not  ||| S:1693 E:1697 ||| RB
all  ||| S:1697 E:1701 ||| DT
horses  ||| S:1701 E:1708 ||| NNS
show  ||| S:1708 E:1713 ||| VBP
the  ||| S:1713 E:1717 ||| DT
same  ||| S:1717 E:1722 ||| JJ
intensity  ||| S:1722 E:1732 ||| NN
of  ||| S:1732 E:1735 ||| IN
systemic  ||| S:1735 E:1744 ||| JJ
inflammatory  ||| S:1744 E:1757 ||| JJ
response ||| S:1757 E:1765 ||| NN
.  ||| S:1765 E:1767 ||| .
